Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
0.6672
-0.0608 (-8.35%)
Dec 31, 2025, 4:00 PM EST - Market closed
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.21 million as of December 31, 2025. Its market cap has decreased by -52.68% in one year.
Market Cap
1.21M
Enterprise Value
-1.72M
1-Year Change
-52.68%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $1.21M, a decrease of -98.21%. That is a compound annual growth rate of -62.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 1.21M | -55.01% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
| Nov 10, 2021 | 67.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |